Syquant Capital Sas Dbv Technologies S.A. Transaction History

Syquant Capital Sas

  • $27.1 Million
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2020

Apr 14, 2020
SELL
$2.33 - $12.98 $1 Million - $5.58 Million
-430,000 Closed
0 $0
Q4 2019

Jan 08, 2020
BUY
$6.75 - $11.15 $2.9 Million - $4.79 Million
430,000 New
430,000 $4.6 Million

Others Institutions Holding DBVT

# of Institutions
2
Shares Held
3.2K
Call Options Held
0
Put Options Held
0
View Full List

About DBV Technologies S.A.

DBVT Quotes by TradingView
  • Ticker DBVT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 187,776,992
  • Market Cap $115M
  • Description
  • DBV Technologies S.A., a clinical-stage biopharmaceutical company, engages in the research and development of epicutaneous immunotherapy products. Its lead product candidate is Viaskin Peanut, an immunotherapy product, which has completed Phase III clinical trial for the treatment of peanut allergies in 4 to 11 years of age children, adolescents...
More about DBVT
Track This Portfolio

Track Syquant Capital Sas Portfolio

Follow Syquant Capital Sas and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Syquant Capital Sas, based on Form 13F filings with the SEC.

News

Stay updated on Syquant Capital Sas with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email